Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$50.42 - $64.29 $500,468 - $638,142
-9,926 Reduced 73.13%
3,647 $219,000
Q1 2024

Apr 15, 2024

BUY
$35.51 - $57.92 $244,415 - $398,663
6,883 Added 102.88%
13,573 $700,000
Q4 2023

Feb 07, 2024

BUY
$20.91 - $40.9 $139,887 - $273,621
6,690 New
6,690 $269,000
Q2 2023

Jul 13, 2023

BUY
$16.37 - $28.9 $74,368 - $131,292
4,543 New
4,543 $130,000

Others Institutions Holding RXST

About RxSight, Inc.


  • Ticker RXST
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 27,638,900
  • Market Cap $1.24B
  • Description
  • RxSight, Inc., a medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. T...
More about RXST
Track This Portfolio

Track Counterpoint Mutual Funds LLC Portfolio

Follow Counterpoint Mutual Funds LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Counterpoint Mutual Funds LLC, based on Form 13F filings with the SEC.

News

Stay updated on Counterpoint Mutual Funds LLC with notifications on news.